Puma Biotechnology Presents Final Results from the Biliary Tract Cohort of the Phase 2 SUMMIT 'Basket' Trial of Neratinib at the ASCO 2022 Annual Meeting | Business Wire
Should You Buy Puma Biotechnology Inc (PBYI) Stock Tuesday?
Puma Biotechnology (PBYI) Stock Climbs On Orphan Drug Designation | Alpha Stock News
Puma Biotechnology Announces Publication of Phase II Clinical Trial of Alisertib in JAMA Oncology | Business Wire
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
PumaBiotech on Twitter: "Puma Biotechnology is dedicated to developing innovative, new treatments to help #cancer patients. As part of our ongoing commitment to the cancer community, we're proud to have participated in #
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz
Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet
The Prognosis For Puma Biotechnology (NASDAQ:PBYI) | Seeking Alpha
Puma (PBYI): Recent Rally Looks Overdone, Unsupported With Fundamentals | Seeking Alpha
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology - Updates, News, Events, Signals & Triggers
Stocks to Watch: Dropbox, Nike, Tronc, Qualcomm, Puma Biotechnology, Invitation Homes, Universal Display - WSJ
Puma Biotechnology falls more than 20%
Puma shares nearly triple on drug news, but options smell 'fishy'
Here's Why Puma Biotechnology Fell 17.2% in April | The Motley Fool
Puma Biotechnology, Inc.
Alan H. Auerbach - Los Angeles Business Journal
PUMA BIOTECHNOLOGY, INC. FORM 10-K - Biotech Due Diligence
Puma Biotechnology Reports Results of PB272 (neratinib) in P-III NALA Trial for Patients with 2L+ HER2+ Metastatic Breast Cancer #ASCO2019
Puma Biotechnology (Nasdaq:PBYI) - Stock Price, News & Analysis - Simply Wall St
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Goldman Sachs Group Cuts Stake in Puma Biotechnology (PBYI)
Puma Biotechnology Surging
